QualityStocksNewsBreaks Archives

ThursdayAug 27, 2026 3:38 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Moves Myelin-Protecting MS Therapy to Phase 2 Development

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) is a biopharmaceutical company focused on advancing innovative therapies and technologies. The company was featured in a recent article that discussed its efforts to advance Lucid-MS, an oral investigational therapy designed to inhibit demyelination and protect myelin in people with multiple sclerosis, as MS drug development increasingly expands beyond controlling inflammation toward neuroprotection and myelin preservation. Preclinical studies demonstrated myelin preservation and functional recovery in animal models, while the company’s Phase 1 program generated safety and pharmacokinetic data supporting further development. The U.S.…

ThursdayAug 27, 2026 3:21 pm

QualityStocksNewsBreaks – Dune Oil Corp. (CSE: DUNE) (OTCQB: TRLEF) (FSE: Z621) Announces Leadership Appointments and Sets 2026 Annual General Meeting

Dune Oil (CSE: DUNE) (OTCQB: TRLEF) (FSE: Z621) announced several leadership appointments, including the appointment of President Scott Lower as CEO and Jordan Coleman as chief operating officer. Sean Stofer, who served as interim CEO during the company transition, will continue as chairman and a director. Dune also appointed Neil Maedel to its board, adding more than 45 years of capital-markets, investment-banking and international resource-sector experience. Dune also announced that its 2026 Annual General Meeting of Shareholders ("AGM") will be held Nov. 16, 2026. Shareholders will be asked to set the number of directors at six, elect directors for the ensuing year, appoint…

ThursdayAug 27, 2026 3:07 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Expands GelrinC Clinical and Commercial Pathways

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC cell-free cartilage repair implant along parallel U.S. clinical and European commercial tracks, with more than half of the 80-patient pivotal Phase III SAGE study enrolled and recruitment targeted for completion in the third quarter of 2026. The FDA-approved single-arm study uses a historical microfracture control dataset owned by Regentis, and the company reports that the first 40 enrolled patients closely match the historical control group in baseline characteristics. In Europe, where GelrinC already has CE Mark approval, Regentis is preparing for broader commercialization through surgeon training, an expanding network of Centers of Excellence…

ThursdayAug 27, 2026 2:29 pm

QualityStocksNewsBreaks – Earth Science Tech Inc. (ETST) Marks Growth as Avenvi Expands Asset Base

Earth Science Tech (OTC: ETST) was featured in a recent article that discussed its strengthened position among OTC-listed companies through consistent financial growth, timely reporting, vertical integration, prudent capital allocation, and ownership of hard real estate assets. Revenue increased to $35.7 million in FY2026 from $33.1 million in FY2025 and $11.95 million in FY2024, while gross profit rose to $25.5 million from $24.3 million and $7.8 million. The company attributes this progress to strategic investments and acquisitions made without adding debt, particularly its purchase of Avenvi, a real estate company whose 13-property portfolio includes the Texas property housing ETST’s Mister Meds…

ThursdayAug 27, 2026 1:50 pm

QualityStocksNewsBreaks – AtlasClear Holdings Inc. (NYSE American: ATCH) to Spotlight Tech-Enabled Financial Services Platform in New York

AtlasClear Holdings (NYSE American: ATCH) will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference in New York City on September 9–10, with President Craig Ridenhour and Executive Chairman John Schaible scheduled to deliver an investor presentation and meet one-on-one with investors. The conference brings together growth companies, investors and industry leaders across life sciences, healthcare and other emerging sectors. AtlasClear is focused on building a technology-enabled financial services platform to provide modern clearing solutions to underserved small and mid-sized financial institutions. To view the full press release, visit https://ibn.fm/XSEus About AtlasClear Holdings Inc. AtlasClear Holdings…

ThursdayAug 27, 2026 12:40 pm

QualityStocksNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Expands Power Champion Agreement to Cover Up to 512 NVIDIA HGX B300 Systems

AZIO AI Holdings (NASDAQ: AZIO) announced that it has expanded its agreement with Power Champion Investment Limited to cover the purchase of up to 384 additional NVIDIA HGX B300 GPU systems. Combined with up to 128 systems announced Aug. 6, 2026, the relationship now covers up to 512 systems, representing an estimated cumulative sales pipeline value of approximately $307 million based on current market pricing. The additional 384 systems represent an estimated incremental sales pipeline value of approximately $230 million. The company emphasized that the figures represent sales pipeline value, not backlog, contracted amounts, orders or revenue forecasts, and no purchase orders have been issued under the expanded agreement. The expansion follows…

ThursdayAug 27, 2026 12:22 pm

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Reports Progress in Texatron(TM) Fusion Testing Program

American Fusion (OTC: AMFN) announced continued progress in development and testing of its proprietary Texatron(TM) Fusion Engine(TM), reporting repeatable magnetic-confinement testing with peak confinement pressures of approximately 100,000 atmospheres. The company is developing the Texatron(TM) around short-duration electromagnetic pulses intended to simultaneously create the plasma temperature, pressure and density and confinement time required for deuterium-helium-3 ("D-He3") fusion. Its next objective is to further develop and characterize these conditions as it works toward fusion ignition and, ultimately, net energy gain. American Fusion also reported calculations comparing its 11-inch, approximately 500 kW development model with a 23-inch, approximately 5 MW model. Under equivalent assumed plasma conditions, the larger configuration has approximately 8.36 times…

ThursdayAug 27, 2026 12:08 pm

QualityStocksNewsBreaks – Wrap Technologies, Inc. (NASDAQ: WRAP) Featured in NetworkNewsWire Editorial on Evolving Counter-Drone Defense Market

Wrap Technologies (NASDAQ: WRAP) was featured in a NetworkNewsWire editorial examining the evolving counter-drone defense market as increasingly autonomous and communications-independent drones challenge conventional radio-frequency detection and jamming systems. The editorial highlights Wrap Technologies exclusive U.S. and NATO rights to commercialize Frenel Imaging TPiCore polarimetric sensing platform, a passive, physics-based detection technology designed to identify objects by material signatures rather than radio emissions. The editorial also examines WrapShield(TM), the company open architecture built around Detect, Orchestrate and Respond capabilities and designed to integrate emerging sensing and response technologies. Wrap recently expanded its partnership with Frenel to pursue additional technologies for WrapShield, with laser directed-energy counter-UAS capability among the first planned integrations. The editorial positions these developments against growing…

ThursdayAug 27, 2026 11:59 am

QualityStocksNewsBreaks – NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Completes Three Large-Animal Procedures Using StereoCED(TM) Platform

NeuroOne (NASDAQ: NMTC) reported the successful completion of three large-animal procedures using its next-generation StereoCED(TM) platform as part of an ongoing preclinical epilepsy research program at the University of Minnesota. In two procedures, NeuroOne drug delivery electrodes delivered a study agent directly into targeted brain tissue while also recording intracranial electrophysiological activity from the same regions, a combination the company believes has not previously been demonstrated in convection-enhanced delivery. The procedures were designed to establish technical feasibility and validate the integrated surgical and drug delivery workflow. NeuroOne said the repeatability demonstrated across the three procedures provides additional confidence as it advances toward the planned launch of StereoCED(TM) for human investigational clinical studies later this quarter. Development…

ThursdayAug 27, 2026 11:55 am

QualityStocksNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Expects to Complete Sarfartoq Rare Earths Project Acquisition Before Sept. 1

Greenland Mines (NASDAQ: GRML) announced that it expects to complete its previously announced acquisition of Neo North Star Resources, Inc., owner of the Sarfartoq Nd-Pr Rare Earths Project in southwest Greenland, before Sept. 1, 2026. The company has received formal approval from the Government of Greenland for the indirect transfer of the Sarfartoq mineral license and completed its recently announced public offering, providing the capital required to fund the $20 million cash portion of the $35 million acquisition. The remaining $15 million will consist of newly issued Greenland Mines common stock, with Neo Performance Materials Inc. (TSX: NEO) becoming a…

Site Search

Company Search

Category: QualityStocksNewsBreaks